PF-03709270
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-03709270, covering 2016-03-10 to 2016-03-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization [Phase 2]